The Ensign Group (ENSG) Stock Price, News & Analysis

Company Overview

The Ensign Group, Inc. is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy. Its assisted and independent living communities provide day-to-day support, social activities and continuity of care for residents who require varying levels of supervision. Home health services extend the company’s therapeutic expertise into patients’ homes, while hospice programs focus on comfort and quality of life for individuals with life-limiting conditions.

Founded in 1999 by Jeffrey M. Willis and headquartered in Mission Viejo, California, The Ensign Group has grown from a single skilled nursing facility to a coast-to-coast operator serving hundreds of locations across multiple states. The company’s strategic focus on facility-level leadership and on-site clinical management supports consistent quality standards and operational efficiencies throughout its network.

Led by founder and Chief Executive Officer Jeffrey M. Willis, supported by a senior leadership team with extensive experience in healthcare administration, The Ensign Group continues to expand its footprint through selective acquisitions and partnerships. Its regional operating offices collaborate closely with center management to maintain regulatory compliance, foster community relationships and implement best practices in patient care.

Key Stats

• Today's Range: $170.44 to $173.28
• 50-Day Range: $169.41 to $210.38
• 52-Week Range: $134.79 to $218.00
• Volume: 447,115 shs
• Average Volume: 579,094 shs
• Market Capitalization: $10.05 billion
• P/E Ratio: 28.00
• Dividend Yield: 0.15%
• Price Target: $216.75
• Consensus Rating: Moderate Buy

The Ensign Group Stock Analysis - MarketRank™

The Ensign Group scored higher than 87% of companies evaluated by MarketBeat, and ranked 62nd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

The Ensign Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

The Ensign Group has a consensus price target of $216.75, representing about 26.1% upside from its current price of $171.94.

Amount of Analyst Coverage

The Ensign Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 6.33%

Earnings Growth

Earnings for The Ensign Group are expected to grow by 6.33% in the coming year, from $6.79 to $7.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of The Ensign Group is 28.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.12.

Price to Earnings Ratio vs. Sector

The P/E ratio of The Ensign Group is 28.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 17.94.

Price to Earnings Growth Ratio

The Ensign Group has a PEG Ratio of 1.69. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

The Ensign Group has a P/B Ratio of 4.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.59% of the float of The Ensign Group has been sold short.

Short Interest Ratio / Days to Cover

The Ensign Group has a short interest ratio ("days to cover") of 3.53, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in The Ensign Group has recently increased by 11.30%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

The Ensign Group has a dividend yield of 0.15%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

The Ensign Group has been increasing its dividend for 18 years.

Dividend Coverage

The dividend payout ratio of The Ensign Group is 4.23%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, The Ensign Group will have a dividend payout ratio of 3.60% next year. This indicates that The Ensign Group will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.89

News Sentiment

The Ensign Group has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for The Ensign Group this week, compared to 5 articles on an average week.

Search Interest

2 people have searched for ENSG on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, The Ensign Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $512,364.00 in company stock.

Percentage Held by Insiders

4.00% of the stock of The Ensign Group is held by insiders.

Percentage Held by Institutions

96.12% of the stock of The Ensign Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 4/30 Dividend: 3/31/2026
• Ex-Dividend for 4/30 Dividend: 3/31/2026
• Last Earnings: 4/30/2026
• Dividend Payable: 4/30/2026
• Today: 5/24/2026
• Next Earnings (Estimated): 7/23/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - NURSING HMS
• Sub-Industry: Health Care Facilities
• Current Symbol: NASDAQ:ENSG
• CIK: 1125376
• Web: www.ensigngroup.net
• Phone: (949) 487-9500
• Fax: 949-540-3007
• Employees: 46,000
• Year Founded: 1999

Price Target and Rating

• Average Price Target for The Ensign Group: $216.75
• High Price Target: $230.00
• Low Price Target: $200.00
• Potential Upside/Downside: +26.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.14
• Trailing P/E Ratio: 28.00
• Forward P/E Ratio: 25.32
• P/E Growth: 1.69
• Net Income: $343.97 million
• Net Margins: 6.89%
• Pretax Margin: 9.06%
• Return on Equity: 16.78%
• Return on Assets: 6.91%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 1.56
• Quick Ratio: 1.56

Sales & Book Value

• Annual Sales: $5.06 billion
• Price / Sales: 1.99
• Cash Flow: $7.83 per share
• Price / Cash Flow: 21.95
• Book Value: $40.54 per share
• Price / Book: 4.24

Miscellaneous

• Outstanding Shares: 58,440,000
• Free Float: 56,107,000
• Market Cap: $10.05 billion
• Optionable: Optionable
• Beta: 0.73